Study on Using CAR-T Cells Targeting CSPG4 for Treating Relapsed or Hard-to-Treat Head and Neck Cancer | Clinical Trial

Study on Using CAR-T Cells Targeting CSPG4 for Treating Relapsed or Hard-to-Treat Head and Neck Cancer | Clinical Trial | Right2Hope